Literature DB >> 35896984

Correction: Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.

Kun Zhang1, Ke Wang1, Chaoguo Zhang1, Xiuli Teng1, Dan Li1, Mingwei Chen2.   

Abstract

Entities:  

Year:  2022        PMID： 35896984      PMCID： PMC9326412          DOI： 10.1186/s12885-022-09836-2

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.638


× No keyword cloud information.
Correction: BMC Cancer 22, 687 (2022) https://doi.org/10.1186/s12885-022-09763-2 Following publication of the original article [1], the authors identified a production error. Figure 8 was not correctly processed by the publisher. The correct version of figure 8 is supplied in this correction article.
Fig. 8

RMSD and RMSF of the SARS-CoV-2 Mpro complexes and DDP4 complexes. A The RMSD of Mpro. B The RMSD of DDP4. C The RMSD of inhibitor 11a and emetine. D The RMSD of omarigliptin and emetine. E The RMSF of Mpro. F The RMSF of DDP4

RMSD and RMSF of the SARS-CoV-2 Mpro complexes and DDP4 complexes. A The RMSD of Mpro. B The RMSD of DDP4. C The RMSD of inhibitor 11a and emetine. D The RMSD of omarigliptin and emetine. E The RMSF of Mpro. F The RMSF of DDP4
  1 in total

1.  Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.

Authors:  Kun Zhang; Ke Wang; Chaoguo Zhang; Xiuli Teng; Dan Li; Mingwei Chen
Journal:  BMC Cancer       Date:  2022-06-22       Impact factor: 4.638
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.